Loading...

Merck & Co., Inc.

MRK•NYSE
Healthcare
Drug Manufacturers - General
$111.90
$-2.72(-2.37%)
U.S. Market opens in 15h 22m

Merck & Co., Inc. (MRK) Stock Overview

Explore Merck & Co., Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap276.6B
P/E Ratio15.27
EPS (TTM)$7.28
ROE0.36%
Fundamental Analysis

AI Price Forecasts

1 Month$108.17
3 Months$108.54
1 Year Target$136.48

MRK Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Merck & Co., Inc. (MRK) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of A, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 37.84, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $136.48.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 15.27 and a market capitalization of 276.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-2.41%
5-Day Change
-3.20%
1-Month Change
-3.88%
3-Month Change
3.40%
6-Month Change
27.85%
Year-to-Date (YTD) Change
6.27%
1-Year Change
40.11%
3-Year Change
-3.52%
5-Year Change
51.31%
All-Time (Max) Change
28192.49%

Contact Information

https://www.merck.com
908 740 4000
126 East Lincoln Avenue, Rahway, NJ, 07065

Company Facts

73,000 Employees
IPO DateJan 13, 1978
CountryUS
Actively Trading

Frequently Asked Questions